Atlas Trials

GC Biopharma Corp

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GC Biopharma Corp

RecordFirmDate
A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults (NCT07728396)GC Biopharma Corp2026-01-28
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults (NCT06997627)GC Biopharma Corp2025-06-05
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease (NCT06858397)GC Biopharma Corp2025-05-14
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA) (NCT06567769)GC Biopharma Corp2024-11-21
Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study (NCT07084246)GC Biopharma Corp2023-06-07
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. (NCT05686759)GC Biopharma Corp2023-04-13
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions (NCT05729386)GC Biopharma Corp2023-02-06
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years (NCT05664152)GC Biopharma Corp2023-02-01
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions (NCT05703984)GC Biopharma Corp2023-01-17
A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ (NCT05422482)GC Biopharma Corp2022-09-20
A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient (NCT05493631)GC Biopharma Corp2022-08-24
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency (NCT04565015)GC Biopharma Corp2020-12-21
An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) (NCT07344376)GC Biopharma Corp2018-05-23

Track GC Biopharma Corp automatically

Every clearance here is in the API, with alerts when new ones post.